6-(1H-pyrazol-1-yl)pyridazine-3-carboxylic acid, 95.0%, 1g

BENZAMIDE, N-CYCLOPROPYL-4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-, 95.0%, 250mg

9'-Phenyl-9'H-9,3':6',9''-tercarbazole, 98%, 1g

2-(methylsulfanyl)-4H,5H,6H,7H-[1,3]thiazolo[4,5-d]pyrimidine-5,7-dione, 98%, 5g

3-(2-Naphthyl)-D-alanine.HCl, 95%, 1g

5-bromo-2-methoxy-4-(trifluoromethyl)benzoic acid, 95%, 250mg

4-[2-N,N-Diethylethoxy]phenyl bromide, 95.0%, 5g

BCTC, 98.0%, 1g

(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

8-Bromo-6-fluorochroman, 95.0%, 250mg

Methyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-naphthoate, 95.0%, 250mg

6-Bromo-4-chloro-1H-indole, 95.0%, 1g

Ethyl 1-isopropyl-4-nitro-1h-pyrazole-3-carboxylate, 97%, 2.5g